Li, Zhuyue
Wang, Kang
Shivappa, Nitin
Hébert, James R.
Chen, Hong
Liu, Hui
Jiang, Xiaolian http://orcid.org/0000-0001-9129-0012
Article History
Received: 19 February 2021
Revised: 31 December 2021
Accepted: 28 January 2022
First Online: 8 February 2022
Competing interests
: Dr. JRH owns controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII®) from the University of South Carolina in order to develop computer and smartphone applications for patient counselling and dietary intervention in clinical settings. Dr. NS is an employee of CHI. The subject matter of this paper will not have any direct bearing on that work, nor has that activity exerted any influence on this project. The remaining authors declare no competing interests.
: Institutional Review Board of the National Cancer Institute approved the study protocol of PLCO Cancer Screening Trial, and all participants provided a written informed consent.
: Not applicable.